tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Francois Brisebois, 202 are a BUY (96.19%), 1 are a SELL (0.48%), 7 are a HOLD (3.33%).
Analyst Francois Brisebois, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 39.2% that have a potential upside of 46.36% achieved within 241 days.
Francois Brisebois’s has documented 405 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DYN, Dyne Therapeutics at 18-Feb-2026.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for KALA (KALA PHARMACEUTICALS) at 4/14/2025. The price target of $15 was fulfilled within 142 days with a profit of $11.51 (329.8%) receiving and performance score of 23.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Sep-2025
$22.5
$0.86 (3.97%)
$20
11 months 8 days ago
(20-Nov-2025)
3/3 (100%)
$-0.44 (-1.92%)
10
Hold Since 05-Nov-2025
11 months 23 days ago
(05-Nov-2025)
34/34 (100%)
$9.61 (102.34%)
366
Buy Since 06-Feb-2024
$20
$-1.64 (-7.58%)
$20
1 years ago
(28-Oct-2025)
4/5 (80%)
$1.41 (7.58%)
278
Buy Since 18-Jul-2025
$20
$-1.64 (-7.58%)
$22
1 years 5 days ago
(23-Oct-2025)
2/2 (100%)
$1.44 (7.76%)
71
Buy Since 30-Jun-2020
$20
$-1.64 (-7.58%)
$24
1 years 5 days ago
(23-Oct-2025)
10/18 (55.56%)
$1.44 (7.76%)
392
What Year was the first public recommendation made by Francois Brisebois?
